Reed's, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a REED research report →
Companydrinkreeds.com
Reed's, Inc. engages in the manufacture and distribution of natural hand-crafted beverages in the craft specialty foods industry in the United States, Canada, Asia, Europe, Australia, and South America. It offers Reed's craft ginger beers; Reed's real ginger ales; Reed's ready to drink products; Virgil's handcrafted sodas; ginger candy; and other ginger beverages under the Reed's brand.
- CEO
- Yumin Dai
- IPO
- 2006
- Employees
- 24
- HQ
- Norwalk, CT, US
Price Chart
Valuation
- Market Cap
- $15.83M
- P/E
- -0.99
- P/S
- 0.51
- P/B
- 7.42
- EV/EBITDA
- -1.12
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 13.65%
- Op Margin
- -62.93%
- Net Margin
- -65.03%
- ROE
- -496.48%
- ROIC
- -154.14%
Growth & Income
- Revenue
- $34.06M · -10.25%
- Net Income
- $-15,847,000 · -20.49%
- EPS
- $-1.91 · -16.46%
- Op Income
- $-15,148,000
- FCF YoY
- -175.89%
Performance & Tape
- 52W High
- $12.00
- 52W Low
- $1.62
- 50D MA
- $3.62
- 200D MA
- $4.52
- Beta
- 0.36
- Avg Volume
- 35.68K
Get TickerSpark's AI analysis on REED
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 27, 26 | Warshall Damian Francis | other | 0 |
| Jan 5, 26 | COHANE NEAL | other | 0 |
| Nov 3, 25 | Johnson Keith William | other | 0 |
| Sep 15, 25 | Tu Michael Carl | other | 0 |
| Sep 15, 25 | Reejsinghani Tina Suman | other | 0 |
| Apr 16, 25 | Wallace Cyril Arthur | other | 0 |
| Jun 4, 25 | Era Regenerative Medicine Ltd | buy | 1,075,269 |
| Apr 14, 25 | Bakker Rudolf Johannes Maria | other | 0 |
| Dec 31, 24 | Era Regenerative Medicine Ltd | other | 0 |
| May 23, 23 | Era Regenerative Medicine Ltd | other | 232,108 |
Our REED Coverage
We haven't published any research on REED yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate REED Report →